• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用与抗CD3和抗CD28抗体偶联的磁珠对人T细胞进行体外扩增的优化。

Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies.

作者信息

Kalamasz Dale, Long S A, Taniguchi Ruth, Buckner Jane H, Berenson Ronald J, Bonyhadi Mark

机构信息

Xcyte Therapies, Inc., Seattle, Washington 98104, USA.

出版信息

J Immunother. 2004 Sep-Oct;27(5):405-18. doi: 10.1097/00002371-200409000-00010.

DOI:10.1097/00002371-200409000-00010
PMID:15314550
Abstract

T-cell receptor engagement and accompanying costimulatory signals control the level of activation and functional potential of individual T cells. The authors previously developed a novel technology in which human T cells are activated and expanded in culture ex vivo using anti-CD3 and anti-CD28 monoclonal antibodies covalently linked to superparamagnetic beads (Xcyte Dynabeads). In this study the addition of N-acetyl L-cysteine (NAC) to the cultures markedly increased the expansion of T cells from human peripheral blood mononuclear cells without diminishing cell function. NAC increased the rate of T-cell division, reduced apoptosis, and increased the percentage of antigen-specific memory T cells in the cultures. The effect of varying the ratio of beads to T cells (1:10-10:1) at culture initiation was also evaluated. Polyclonal T cells were expanded at all bead-to-T cell ratios tested (range 1:10-10:1). While high bead-to-T cell ratios (5:1 and 10:1) deleted, low ratios (1:10 and 1:5) preserved memory T cells directed against cytomegalovirus, Epstein-Barr virus, and influenza virus antigens. Adding more anti-CD3/anti-CD28 beads during the culture led to further expansion of T cells. Experiments also revealed that reducing the amount of anti-CD3 antibodies relative to the amount of anti-CD28 antibodies on the beads favored the proliferation of antigen-specific T cells. In summary, these data indicate that T cell-stimulating effects of anti-CD3/anti-CD28 beads can be further manipulated to control the expansion of antigen-specific memory T cells and can be used to rapidly expand antigen-specific T cells ex vivo for potential clinical applications.

摘要

T细胞受体的结合以及伴随的共刺激信号控制着单个T细胞的激活水平和功能潜力。作者之前开发了一种新技术,即使用与超顺磁性珠子(Xcyte Dynabeads)共价连接的抗CD3和抗CD28单克隆抗体,在体外培养中激活并扩增人T细胞。在本研究中,向培养物中添加N-乙酰半胱氨酸(NAC)可显著增加人外周血单个核细胞中T细胞的扩增,且不影响细胞功能。NAC提高了T细胞的分裂速率,减少了细胞凋亡,并增加了培养物中抗原特异性记忆T细胞的百分比。还评估了在培养起始时改变珠子与T细胞比例(1:10 - 10:1)的影响。在所有测试的珠子与T细胞比例(范围1:10 - 10:1)下,多克隆T细胞均得到了扩增。虽然高珠子与T细胞比例(5:1和10:1)会导致细胞缺失,但低比例(1:10和1:5)可保留针对巨细胞病毒、EB病毒和流感病毒抗原的记忆T细胞。在培养过程中添加更多的抗CD3/抗CD28珠子可导致T细胞进一步扩增。实验还表明,相对于珠子上抗CD28抗体的量减少抗CD3抗体的量有利于抗原特异性T细胞的增殖。总之,这些数据表明,抗CD3/抗CD28珠子的T细胞刺激作用可进一步调控,以控制抗原特异性记忆T细胞的扩增,并可用于在体外快速扩增抗原特异性T细胞,用于潜在的临床应用。

相似文献

1
Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies.使用与抗CD3和抗CD28抗体偶联的磁珠对人T细胞进行体外扩增的优化。
J Immunother. 2004 Sep-Oct;27(5):405-18. doi: 10.1097/00002371-200409000-00010.
2
Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion.基于疫苗接种、体外再刺激和 CD3/CD28 磁珠诱导的 T 细胞扩增,生成自体肿瘤特异性 T 细胞进行过继转移。
Cancer Immunol Immunother. 2012 Aug;61(8):1221-31. doi: 10.1007/s00262-011-1199-8. Epub 2012 Jan 12.
3
In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T lymphocytes by anti-CD3/CD28/CD137 magnetic beads.采用抗 CD3/CD28/CD137 磁珠体外刺激和扩增人肿瘤反应性 CD8+细胞毒性 T 淋巴细胞。
Scand J Immunol. 2011 Aug;74(2):155-64. doi: 10.1111/j.1365-3083.2011.02564.x.
4
Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2.不同的细胞因子和刺激条件会影响针对肿瘤抗原GD2的第三代嵌合抗原受体T细胞的扩增和免疫表型。
Cytotherapy. 2015 Apr;17(4):487-95. doi: 10.1016/j.jcyt.2014.12.002. Epub 2015 Jan 6.
5
Lipid Microbubble-Conjugated Anti-CD3 and Anti-CD28 Antibodies (Microbubble-Based Human T Cell Activator) Offer Superior Long-Term Expansion of Human Naive T Cells In Vitro.脂质微泡偶联抗 CD3 和抗 CD28 抗体(基于微泡的人 T 细胞激活剂)可在体外更有效地长期扩增人初始 T 细胞。
Immunohorizons. 2020 Aug 7;4(8):475-484. doi: 10.4049/immunohorizons.2000056.
6
T cell stimulation and expansion by SunTag-based clustering of anti-CD3/CD28 scFv.基于 SunTag 的抗 CD3/CD28 scFv 聚类实现 T 细胞的刺激和扩增。
Aging (Albany NY). 2020 Jun 10;12(11):11061-11070. doi: 10.18632/aging.103318.
7
4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.在为过继性免疫治疗产生CD8 + 细胞毒性淋巴细胞方面,4-1BB优于CD28共刺激。
J Immunol. 2007 Oct 1;179(7):4910-8. doi: 10.4049/jimmunol.179.7.4910.
8
In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia.在体外激活CD3和CD28可纠正慢性淋巴细胞白血病中的T细胞缺陷。
J Immunol. 2005 Feb 15;174(4):2366-75. doi: 10.4049/jimmunol.174.4.2366.
9
Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma.抗CD3/抗CD28磁珠刺激可克服头颈部鳞状细胞癌患者的CD3无反应性。
Arch Otolaryngol Head Neck Surg. 2000 Apr;126(4):473-9. doi: 10.1001/archotol.126.4.473.
10
The Effects of Anti-CD3/CD28 Coated Beads and IL-2 on Expanded T Cell for Immunotherapy.抗CD3/CD28包被磁珠和白细胞介素-2对用于免疫治疗的扩增T细胞的影响
Adv Clin Exp Med. 2016 Sep-Oct;25(5):821-828. doi: 10.17219/acem/35771.

引用本文的文献

1
Optimizing canine T cell activation, expansion, and transduction.优化犬类T细胞的激活、扩增和转导。
PLoS One. 2025 Sep 11;20(9):e0324403. doi: 10.1371/journal.pone.0324403. eCollection 2025.
2
Engineering mRNA CAR-T Cells for Cancer Immunotherapy.用于癌症免疫治疗的工程化信使核糖核酸嵌合抗原受体T细胞
Methods Mol Biol. 2025;2965:285-321. doi: 10.1007/978-1-0716-4742-4_14.
3
A deep single cell mass cytometry approach to capture canonical and noncanonical cell cycle states.一种用于捕获典型和非典型细胞周期状态的深度单细胞质谱流式细胞术方法。
bioRxiv. 2025 Jul 10:2025.07.08.663243. doi: 10.1101/2025.07.08.663243.
4
Engineering Functional Particles to Modulate T Cell Responses.工程化功能性颗粒以调节T细胞反应。
Acc Mater Res. 2024 Jul 18;5(9):1048-1058. doi: 10.1021/accountsmr.4c00105. eCollection 2024 Sep 27.
5
T Cell Activators Exhibit Distinct Downstream Effects on Chimeric Antigen Receptor T Cell Phenotype and Function.T 细胞激活剂对嵌合抗原受体 T 细胞表型和功能表现出不同的下游效应。
Immunohorizons. 2024 Jun 1;8(6):404-414. doi: 10.4049/immunohorizons.2400008.
6
Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer Immunotherapy.抗原呈递细胞模拟脂质纳米颗粒用于快速 mRNA CAR T 细胞癌症免疫疗法。
Adv Mater. 2024 Jun;36(26):e2313226. doi: 10.1002/adma.202313226. Epub 2024 Mar 15.
7
Examining the effect of activated cytotoxic (CD8) T-cell exosomes to the lung cancer.探讨激活的细胞毒性(CD8)T 细胞外泌体对肺癌的影响。
Med Oncol. 2023 Nov 15;40(12):359. doi: 10.1007/s12032-023-02198-0.
8
Construction of micro-nano robots: living cells and functionalized biological cell membranes.微纳机器人的构建:活细胞与功能化生物细胞膜
Front Bioeng Biotechnol. 2023 Sep 12;11:1277964. doi: 10.3389/fbioe.2023.1277964. eCollection 2023.
9
Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)Therapy.抗巨细胞病毒T细胞在癌症(免疫)治疗中的应用
Cancers (Basel). 2023 Jul 25;15(15):3767. doi: 10.3390/cancers15153767.
10
Therapeutic Potential of Ex Vivo Expanded γδ T Cells against Osteosarcoma Cells.γδ T 细胞过继扩增治疗骨肉瘤的研究进展
Cells. 2022 Jul 11;11(14):2164. doi: 10.3390/cells11142164.